Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Activation of caspase-6 and cleavage of caspase-6 substrates is an early event in NMDA receptor-mediated excitotoxicity.

Journal of neuroscience research | 2018

Excitotoxicity, due to overstimulation of N-methyl D-aspartate receptors (NMDARs), has a pivotal role in many neurological disorders. However, NMDAR antagonists often cause side effects, and identifying more druggable therapeutic targets for NMDAR excitotoxicity is an important goal. Activation of caspases is a downstream effect of excitotoxicity that may be critically involved in NMDAR-mediated cell death. Caspase-6 (casp6) in particular has been shown to play a key role in the pathogenesis of stroke, Huntington disease, and Alzheimer disease. Using N-methyl D-aspartate (NMDA)-induced excitotoxic injuries of primary rat neurons, we demonstrate that there is an early increase in caspase profiles after an excitotoxic event at the level of mRNA, protein, and activity. Casp6 is elevated and activated first, followed by caspase-8 and caspase-3. Similarly, known casp6 substrates huntingtin, as well as novel casp6 substrates serine/threonine kinase 3 and death domain-associated protein, are cleaved in similar temporal patterns post NMDA. On the basis of these data, we propose that casp6 may be an initiator caspase in apoptotic cascades leading to neuronal death after an excitotoxic event and suggest casp6 as a potential therapeutic target for neurological disorders where NMDAR-mediated excitotoxicity has been shown to play a role.

Pubmed ID: 29193273 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Calnexin - ER membrane marker antibody (antibody)

RRID:AB_1310022

This polyclonal targets Calnexin - ER membrane marker antibody

View all literature mentions

STK3 antibody [EP1466Y] (antibody)

RRID:AB_882734

This monoclonal targets STK3

View all literature mentions

Caspase-3 Antibody (antibody)

RRID:AB_331439

This polyclonal targets Caspase-3

View all literature mentions

Caspase-6 Antibody (antibody)

RRID:AB_10829240

This polyclonal targets Caspase-6

View all literature mentions

caspase-8 p18 (H-134) (antibody)

RRID:AB_2068330

This polyclonal targets CASP8

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

HotHsd:SD (organism)

RRID:RGD_5508397

Rattus norvegicus with name HotHsd:SD from RGD.

View all literature mentions

HotHsd:SD (organism)

RRID:RGD_5508397

Rattus norvegicus with name HotHsd:SD from RGD.

View all literature mentions

Calnexin - ER membrane marker antibody (antibody)

RRID:AB_1310022

This polyclonal targets Calnexin - ER membrane marker antibody

View all literature mentions